Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 5

Results: 16

Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 649, doi. 10.1007/s00262-006-0221-z

By:

Stott, Brandon;
Korbelik, Mladen

Publication type:

Article

Induction of apoptosis and immune response by all- trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 615, doi. 10.1007/s00262-006-0219-6

By:

Haque, Azizul;
Das, Arabinda;
Hajiaghamohseni, Laela M.;
Younger, Austin;
Banik, Naren L.;
Ray, Swapan K.

Publication type:

Article

Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 627, doi. 10.1007/s00262-006-0220-0

By:

Putz, Thomas;
Ramoner, Reinhold;
Gander, Hubert;
Rahm, Andrea;
Bartsch, Georg;
Bernardo, Katussevani;
Ramsay, Steven;
Thurnher, Martin

Publication type:

Article

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 659, doi. 10.1007/s00262-006-0222-y

By:

Kyte, Jon Amund;
Kvalheim, Gunnar;
Lislerud, Kari thor;
thor Straten, Per;
Dueland, Svein;
Aamdal, Steinar;
Gaudernack, Gustav

Publication type:

Article

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 641, doi. 10.1007/s00262-006-0225-8

By:

Ghiringhelli, François;
Menard, Cedric;
Puig, Pierre;
Ladoire, Sylvain;
Roux, Stephan;
Martin, François;
Solary, Eric;
Le Cesne, Axel;
Zitvogel, Laurence;
Chauffert, Bruno

Publication type:

Article

Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 587, doi. 10.1007/s00262-006-0214-y

By:

Verdegaal, Elizabeth M. E.;
Hoogstraten, Conny;
Sandel, Maro H.;
Kuppen, Peter J. K.;
Brink, Antoinette A. T. P.;
Claas, Frans H. J.;
Gorsira, Michael C. B.;
Graadt van Roggen, J. Frans;
Osanto, Susanne

Publication type:

Article

Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 689, doi. 10.1007/s00262-006-0216-9

By:

Minami, Takafumi;
Matsueda, Satoko;
Takedatsu, Hiroko;
Tanaka, Masahiro;
Noguchi, Masanori;
Uemura, Hirotsugu;
Itoh, Kyogo;
Harada, Mamoru

Publication type:

Article

Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund–Wistar rats.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 725, doi. 10.1007/s00262-006-0223-x

By:

Heinrich, Julie E.;
Pollard, Morris;
Wolter, William A.;
Zhong Liang;
Hui Song;
Rosen, Elliot D.;
Suckow, Mark A.

Publication type:

Article

Phase II study of interleukin-2 and 13- cis-retinoic acid as maintenance therapy in metastatic colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 699, doi. 10.1007/s00262-006-0224-9

By:

Recchia, Francesco;
Saggio, Gaetano;
Cesta, Alisia;
Candeloro, Giampiero;
Di Blasio, Anna;
Amiconi, Giovanna;
Lombardo, Marco;
Nuzzo, Antonio;
Lalli, Angelo;
Alesse, Edoardo;
Necozione, Stefano;
Rea, Silvio

Publication type:

Article

Ii-Key/HER-2/ neu(776–790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/ neu+ tumors.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 601, doi. 10.1007/s00262-006-0213-z

By:

Sotiriadou, Nectaria N.;
Kallinteris, Nikoletta L.;
Gritzapis, Angelos D.;
Voutsas, Ioannis F.;
Papamichail, Michael;
von Hofe, Eric;
Humphreys, Robert E.;
Pavlis, Theodoros;
Perez, Sonia A.;
Baxevanis, Constantin N.

Publication type:

Article

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 709, doi. 10.1007/s00262-006-0226-7

By:

Cabrera, Teresa;
Lara, Ester;
Romero, José M.;
Maleno, Isabel;
Real, Luis;
Ruiz-Cabello, Francisco;
Valero, Pedro;
Camacho, Francisco M.;
Garrido, Federico

Publication type:

Article

HLA-A0201 positive pancreatic cell lines: new findings and discrepancies.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 719, doi. 10.1007/s00262-006-0217-8

By:

Kuichun Zhu;
Lizee, Gregory;
Cano, Pedro;
Fernando-Vina, Marcelo;
Baoan Ji;
Abbruzzese, James;
Hwu, Patrick;
Radvanyi, Laszlo;
Chang, David Z.

Publication type:

Article

Tumor specific phage particles promote tumor regression in a mouse melanoma model.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 677, doi. 10.1007/s00262-006-0227-6

By:

Eriksson, Fredrik;
Culp, W. David;
Massey, Robert;
Egevad, Lars;
Garland, Donita;
Persson, Mats A. A.;
Pisa, Pavel

Publication type:

Article

Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 731, doi. 10.1007/s00262-006-0249-0

By:

Hombach, Andreas;
Abken, Hinrich

Publication type:

Article

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.

Published in:

Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 739, doi. 10.1007/s00262-006-0272-1

By:

Blank, Christian;
Mackensen, Andreas

Publication type:

Article

Acknowledgement.

Published in:: Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 747, doi. 10.1007/s00262-007-0287-2
Publication type:: Article

Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 5

Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.

Induction of apoptosis and immune response by all- trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.

Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells.

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.

Metronomic cyclophosphamide regimen selectively depletes CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells and restores T and NK effector functions in end stage cancer patients.

Functional CD8<sup>+</sup> T cells infiltrate into nonsmall cell lung carcinoma.

Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.

Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund–Wistar rats.

Phase II study of interleukin-2 and 13- cis-retinoic acid as maintenance therapy in metastatic colorectal cancer.

Ii-Key/HER-2/ neu(776–790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/ neu+ tumors.

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

HLA-A0201 positive pancreatic cell lines: new findings and discrepancies.

Tumor specific phage particles promote tumor regression in a mouse melanoma model.

Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy.

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.

Acknowledgement.